104 related articles for article (PubMed ID: 38945408)
1. Comparative analysis of lipid-peptide nanoparticles prepared via microfluidics, reverse phase evaporation, and ouzo techniques for efficient plasmid DNA delivery.
Mashal M; Attia N; Maldonado I; Enríquez Rodríguez L; Gallego I; Puras G; Pedraz JL
Eur J Pharm Biopharm; 2024 Jun; ():114385. PubMed ID: 38945408
[TBL] [Abstract][Full Text] [Related]
2. Lysozyme-loaded lipid-polymer hybrid nanoparticles: preparation, characterization and colloidal stability evaluation.
Devrim B; Kara A; Vural İ; Bozkır A
Drug Dev Ind Pharm; 2016 Nov; 42(11):1865-76. PubMed ID: 27091346
[TBL] [Abstract][Full Text] [Related]
3. Polyphosphate coated nanoparticles: Enzyme-activated charge-reversal gene delivery systems.
Akkuş-Dağdeviren ZB; Arısoy S; Friedl JD; Fürst A; Saleh A; Bernkop-Schnürch A
Int J Pharm; 2023 Nov; 646():123474. PubMed ID: 37793466
[TBL] [Abstract][Full Text] [Related]
4. Fabrication Of Dual pH/redox-Responsive Lipid-Polymer Hybrid Nanoparticles For Anticancer Drug Delivery And Controlled Release.
Men W; Zhu P; Dong S; Liu W; Zhou K; Bai Y; Liu X; Gong S; Zhang CY; Zhang S
Int J Nanomedicine; 2019; 14():8001-8011. PubMed ID: 31632014
[TBL] [Abstract][Full Text] [Related]
5. Preparation and evaluation of lipid emulsified docetaxel-loaded nanoparticles.
Zhang F; Chang M; Yu Y; Zhang Y; Liu G; Wei T; Zuo T; Guan Y; Lin G; Zhao Z
J Pharm Pharmacol; 2015 Nov; 67(11):1546-55. PubMed ID: 26256262
[TBL] [Abstract][Full Text] [Related]
6. Mechanistic Insights into the Superior DNA Delivery Efficiency of Multicomponent Lipid Nanoparticles: An In Vitro and In Vivo Study.
Quagliarini E; Wang J; Renzi S; Cui L; Digiacomo L; Ferri G; Pesce L; De Lorenzi V; Matteoli G; Amenitsch H; Masuelli L; Bei R; Pozzi D; Amici A; Cardarelli F; Marchini C; Caracciolo G
ACS Appl Mater Interfaces; 2022 Dec; 14(51):56666-56677. PubMed ID: 36524967
[TBL] [Abstract][Full Text] [Related]
7. Strategies for Improved pDNA Loading and Protection Using Cationic and Neutral LNPs with Industrial Scalability Potential Using Microfluidic Technology.
Ottonelli I; Adani E; Bighinati A; Cuoghi S; Tosi G; Vandelli MA; Ruozi B; Marigo V; Duskey JT
Int J Nanomedicine; 2024; 19():4235-4251. PubMed ID: 38766661
[TBL] [Abstract][Full Text] [Related]
8. Size-controlled lipid nanoparticle production using turbulent mixing to enhance oral DNA delivery.
He Z; Hu Y; Nie T; Tang H; Zhu J; Chen K; Liu L; Leong KW; Chen Y; Mao HQ
Acta Biomater; 2018 Nov; 81():195-207. PubMed ID: 30267888
[TBL] [Abstract][Full Text] [Related]
9. Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform.
Bailey-Hytholt CM; Ghosh P; Dugas J; Zarraga IE; Bandekar A
J Vis Exp; 2021 Feb; (168):. PubMed ID: 33720139
[TBL] [Abstract][Full Text] [Related]
10. A brain glioma gene delivery strategy by angiopep-2 and TAT-modified magnetic lipid-polymer hybrid nanoparticles.
Qiao L; Qin Y; Wang Y; Liang Y; Zhu D; Xiong W; Li L; Bao D; Zhang L; Jin X
RSC Adv; 2020 Nov; 10(68):41471-41481. PubMed ID: 35516547
[TBL] [Abstract][Full Text] [Related]
11. CD44-Targeted Lipid Polymer Hybrid Nanoparticles Enhance Anti-Breast Cancer Effect of
Suksiriworapong J; Pongprasert N; Bunsupa S; Taresco V; Crucitti VC; Janurai T; Phruttiwanichakun P; Sakchaisri K; Wongrakpanich A
Pharmaceutics; 2023 Jun; 15(6):. PubMed ID: 37376218
[TBL] [Abstract][Full Text] [Related]
12. Manufacturing Considerations for the Development of Lipid Nanoparticles Using Microfluidics.
Roces CB; Lou G; Jain N; Abraham S; Thomas A; Halbert GW; Perrie Y
Pharmaceutics; 2020 Nov; 12(11):. PubMed ID: 33203082
[TBL] [Abstract][Full Text] [Related]
13. Discovery and in vivo evaluation of novel RGD-modified lipid-polymer hybrid nanoparticles for targeted drug delivery.
Zhao Y; Lin D; Wu F; Guo L; He G; Ouyang L; Song X; Huang W; Li X
Int J Mol Sci; 2014 Sep; 15(10):17565-76. PubMed ID: 25268623
[TBL] [Abstract][Full Text] [Related]
14. Stability Criterion for the Assembly of Core-Shell Lipid-Polymer-Nucleic Acid Nanoparticles.
Paris JL; Gaspar R; Coelho F; De Beule PAA; Silva BFB
ACS Nano; 2023 Sep; 17(17):17587-17594. PubMed ID: 37581895
[TBL] [Abstract][Full Text] [Related]
15. Investigations into mRNA Lipid Nanoparticles Shelf-Life Stability under Nonfrozen Conditions.
Reinhart AG; Osterwald A; Ringler P; Leiser Y; Lauer ME; Martin RE; Ullmer C; Schumacher F; Korn C; Keller M
Mol Pharm; 2023 Dec; 20(12):6492-6503. PubMed ID: 37975733
[TBL] [Abstract][Full Text] [Related]
16. Niosomes-based gene delivery systems for effective transfection of human mesenchymal stem cells.
Carballo-Pedrares N; Kattar A; Concheiro A; Alvarez-Lorenzo C; Rey-Rico A
Mater Sci Eng C Mater Biol Appl; 2021 Sep; 128():112307. PubMed ID: 34474858
[TBL] [Abstract][Full Text] [Related]
17. Microfluidic formulation of lipid/polymer hybrid nanoparticles for plasmid DNA (pDNA) delivery.
Santhanes D; Wilkins A; Zhang H; John Aitken R; Liang M
Int J Pharm; 2022 Nov; 627():122223. PubMed ID: 36155792
[TBL] [Abstract][Full Text] [Related]
18. pDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles.
Vighi E; Ruozi B; Montanari M; Battini R; Leo E
Int J Pharm; 2010 Apr; 389(1-2):254-61. PubMed ID: 20100555
[TBL] [Abstract][Full Text] [Related]
19. Intracellular trafficking kinetics of nucleic acid escape from lipid nanoparticles via fluorescence imaging.
M Bailey-Hytholt C; Ulinski G; Dugas J; Haines M; Lazebnik M; Piepenhagen P; E Zarraga I; Bandekar A
Curr Pharm Biotechnol; 2023 Apr; ():. PubMed ID: 37016519
[TBL] [Abstract][Full Text] [Related]
20. Single-step microfluidic synthesis of transferrin-conjugated lipid nanoparticles for siRNA delivery.
Li Y; Lee RJ; Huang X; Li Y; Lv B; Wang T; Qi Y; Hao F; Lu J; Meng Q; Teng L; Zhou Y; Xie J; Teng L
Nanomedicine; 2017 Feb; 13(2):371-381. PubMed ID: 27720989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
